Middle East & Africa Middle East & Africa Biosimilars Market by Product, Type of Manufacturing, Indication, Region, Trends, Competitive Analysis, and Growth Opportunities, Key Insights.
Speak To Analyst

Overview

Middle East & Africa Biosimilars Market from Consainsights analyses the Middle East & Africa Biosimilars Market in the Life Sciences industry over the forecast period to 2026.

Middle East & Africa Biosimilars research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Middle East & Africa Biosimilars segmentation includes Product, Type of Manufacturing, Indication and Geography.

Market analysis on the basis of Product include Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Calcitonin. This segmentation encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Type of Manufacturing, the Middle East & Africa Biosimilars Market analysis covers In-House Manufacturing, Contract Manufacturing.

Based on the Indication, the Middle East & Africa Biosimilars Market analysis covers Oncology, Chronic Diseases, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications.

Key companies operating in the market include Sandoz, Pfizer, Eli Lilly, Teva Pharmaceutical, Celltrion, Biocon, Amgen and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

The Middle East & Africa Biosimilars Market is segmented into the following categories:

Middle East & Africa Biosimilars Market by Product:

  • Monoclonal Antibodies
  • Insulin
  • Granulocyte Colony-Stimulating Factor
  • Erythropoietin
  • Recombinant Human Growth Hormone
  • Etanercept
  • Follitropin
  • Teriparatide
  • Interferons
  • Enoxaparin Sodium
  • Glucagon
  • Calcitonin

Middle East & Africa Biosimilars Market by Type of Manufacturing:

  • In-House Manufacturing
  • Contract Manufacturing

Middle East & Africa Biosimilars Market by Indication:

  • Oncology
  • Chronic Diseases
  • Autoimmune Diseases
  • Blood Disorders
  • Growth Hormone Deficiency
  • Infectious Diseases
  • Other Indications

Table of Contents

  1. Executive Summary

  2. Middle East & Africa Biosimilars Market Overview

    1. Middle East & Africa Biosimilars Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Middle East & Africa Biosimilars Market 360° Synopsis: Overview
  3. Middle East & Africa Biosimilars Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Middle East & Africa Biosimilars Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Middle East & Africa Biosimilars Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Middle East & Africa Biosimilars Market: Product

    1. Introduction
    2. Monoclonal Antibodies: Market Trends, Size, and Forecast (2017-2026)

      1. Infliximab
      2. Rituximab
      3. Trastuzumab
      4. Adalimumab
      5. Other Monoclonal Antibodies
    3. Insulin: Market Trends, Size, and Forecast (2017-2026)
    4. Granulocyte Colony-Stimulating Factor: Market Trends, Size, and Forecast (2017-2026)
    5. Erythropoietin: Market Trends, Size, and Forecast (2017-2026)
    6. Recombinant Human Growth Hormone: Market Trends, Size, and Forecast (2017-2026)
    7. Etanercept: Market Trends, Size, and Forecast (2017-2026)
    8. Follitropin: Market Trends, Size, and Forecast (2017-2026)
    9. Teriparatide: Market Trends, Size, and Forecast (2017-2026)
    10. Interferons: Market Trends, Size, and Forecast (2017-2026)
    11. Enoxaparin Sodium: Market Trends, Size, and Forecast (2017-2026)
    12. Glucagon: Market Trends, Size, and Forecast (2017-2026)
    13. Calcitonin: Market Trends, Size, and Forecast (2017-2026)
  6. Middle East & Africa Biosimilars Market: Type of Manufacturing

    1. Introduction
    2. In-House Manufacturing: Market Trends, Size, and Forecast (2017-2026)
    3. Contract Manufacturing: Market Trends, Size, and Forecast (2017-2026)
  7. Middle East & Africa Biosimilars Market: Indication

    1. Introduction
    2. Oncology: Market Trends, Size, and Forecast (2017-2026)
    3. Chronic Diseases: Market Trends, Size, and Forecast (2017-2026)
    4. Autoimmune Diseases: Market Trends, Size, and Forecast (2017-2026)
    5. Blood Disorders: Market Trends, Size, and Forecast (2017-2026)
    6. Growth Hormone Deficiency: Market Trends, Size, and Forecast (2017-2026)
    7. Infectious Diseases: Market Trends, Size, and Forecast (2017-2026)
    8. Other Indications: Market Trends, Size, and Forecast (2017-2026)
  8. Middle East & Africa Biosimilars Market: Country

    1. Introduction
    2. Middle East: Market Trends, Size, and Forecast (2017-2026)
    3. Africa: Market Trends, Size, and Forecast (2017-2026)
    4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  9. Middle East & Africa Biosimilars Market: Company Analysis

    1. Introduction
    2. Sandoz

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Pfizer

    4. Eli Lilly

    5. Teva Pharmaceutical

    6. Celltrion

    7. Biocon

    8. Amgen

    9. Samsung Biologics

    10. Mylan

    11. Dr. Reddy’s Laboratories

    12. Stada Arzneimittel Ag

    13. Coherus Biosciences

    14. Biocad

    15. Amega Biotech

    16. Probiomed

    17. Boehringer Ingelheim

    18. Apotex

    19. Fresenius Kabi

    20. Gedeon Richter

    21. Mabxience

  10. Middle East & Africa Biosimilars Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  11. Middle East & Africa Biosimilars Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  12. Industry & Analysts Insights for Success

  13. Research Methodology

  14. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures

Middle East & Africa Biosimilars Market: Structure

Middle East & Africa Biosimilars Market: Value Chain Analysis

Middle East & Africa Biosimilars Market: Porter's Five Forces Model

Middle East & Africa Biosimilars Market: Market Dynamics

Middle East & Africa Biosimilars Market, By Product, 2017-2026 (USD Million)

Middle East & Africa Biosimilars Market, By Type of Manufacturing, 2017-2026 (USD Million)

Middle East & Africa Biosimilars Market, By Indication, 2017-2026 (USD Million)

Middle East Biosimilars Market, By Product, 2017-2026 (USD Million)

Middle East Biosimilars Market, By Type of Manufacturing, 2017-2026 (USD Million)

Middle East Biosimilars Market, By Indication, 2017-2026 (USD Million)

Africa Biosimilars Market, By Product, 2017-2026 (USD Million)

Africa Biosimilars Market, By Type of Manufacturing, 2017-2026 (USD Million)

Africa Biosimilars Market, By Indication, 2017-2026 (USD Million)

Rest of Middle East & Africa Biosimilars Market, By Product, 2017-2026 (USD Million)

Rest of Middle East & Africa Biosimilars Market, By Type of Manufacturing, 2017-2026 (USD Million)

Rest of Middle East & Africa Biosimilars Market, By Indication, 2017-2026 (USD Million)

List of Tables

Middle East & Africa Biosimilars Market, By Product, 2017-2026 (USD Million)

Middle East & Africa Biosimilars Market, By Type of Manufacturing, 2017-2026 (USD Million)

Middle East & Africa Biosimilars Market, By Indication, 2017-2026 (USD Million)

Middle East Biosimilars Market, By Product, 2017-2026 (USD Million)

Middle East Biosimilars Market, By Type of Manufacturing, 2017-2026 (USD Million)

Middle East Biosimilars Market, By Indication, 2017-2026 (USD Million)

Africa Biosimilars Market, By Product, 2017-2026 (USD Million)

Africa Biosimilars Market, By Type of Manufacturing, 2017-2026 (USD Million)

Africa Biosimilars Market, By Indication, 2017-2026 (USD Million)

Rest of Middle East & Africa Biosimilars Market, By Product, 2017-2026 (USD Million)

Rest of Middle East & Africa Biosimilars Market, By Type of Manufacturing, 2017-2026 (USD Million)

Rest of Middle East & Africa Biosimilars Market, By Indication, 2017-2026 (USD Million)